Skip to main content

Table 1 Data collection schedule

From: A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma after surgery: the HSCK-010 trial protocol

Follow-up

 

Inclusion

Surgery

RT

M2

M4

M6

Mxa

Consent

      

Medical History

      

Physical examinations and vital signs

  

Blood routine, Hepatic and Renal Function

Pregnancy Test (Childbearing Age Women)

      

Dosimetric MRI + CT Scan

  

    

MRI (T1 enhanced, T2 FLAIR)

 

 

KPS Score

QLQ-C30 questionnaire

MMSE questionnaire

Toxicity Evaluation (CTCAE 5.0)

  1. aThe follow-up will be done every two months till death or the patient withdrawal from the study